THERAPEUTIC CLASS

Metabolic Control in Type 1 Diabetes: Is Adjunctive Therapy the Way Forward?

---

Despite advances in insulin therapies, patients with type 1 diabetes (T1DM) have a shorter life span due to hyperglycaemia-induced vascular disease and hypoglycaemic complications secondary to insulin therapy. Restricting therapy for T1DM to insulin replacement is perhaps an over-simplistic approach, and we focus in this work on reviewing the role of adjuvant therapy
in this population.

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Endocrine & Metabolic system
Glumin
Diabemin

Specific Detail Info

Diabetes Ther

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment